Risk Management in Early Phase Clinical Trials
Thursday 29th October, 12.30 – 17.00
Academy of Medical Sciences, London
We are pleased to include below the presentations from this year’s AHPPI Annual Meeting.
Please click the links in or near each speaker’s name to download and open a PDF of the presentation.
|13.00||Introduction to the AHPPI Annual Meeting||Prof Keith Wesnes, AHPPI Chair|
|13.15||Risk Management in a CRO Phase I Unit||Dr John Lambert, PAREXEL|
|13.50||Risk Management for Early Trials in biologicals||Dr Richard FitzGerald, Royal Liverpool University Hospital|
|14:20||Tea/Coffee & Networking|
|14:55||Cardiac Safety – the industry and regulatory perspectives||Dr Boaz Mendzelevski, BioClinica and Dr Krishna Prasad, MHRA|
|15:35||Use of a novel risk rating system in clinical trials||Dr Brian Leaker, Respiratory Clinical Trials Ltd, Queen Anne Street Medical Centre|
|16:05||Introduction to EUFEMED & European Training Course in Human Pharmacology||Dr Jörg Täubel, EUFEMED|
|16:20||Update on the implementation of the new EU Clinical Trial Regulation’s transparency rules for early phase trials||Dr Ulrike Lorch, AHPPI Chair-elect|
|16:40||AHPPI Updates||Dr Peter Dewland, AHPPI Treasurer, Dr Tim Hardman & Steffan Stringer, AHPPI Committee (slides, speaker notes)|
|17:00||Closing Remarks followed by drinks reception||Prof Keith Wesnes, AHPPI Chair|
We were delighted to be sponsored by BioKinetic Europe and Niche Science & Technology for this year’s programme.